All4NutraNo products in the cart.
All4NutraStartseite » News » FDA » Page 5
Purpose Mixing with liquids or soft foods is a common procedure to improve acceptability of oral medicines in children but...
Liposomes have been considered promising and versatile drug vesicles. Compared with traditional drug delivery systems, liposomes exhibit better properties, including...
The FDA approved 50 novel drugs in 2021, including the first KRAS inhibitor for cancer and the first anti-amyloid antibody...
TORONTO/ANDERNACH, December 20, 2021 — PharmaTher Holdings Ltd. (“PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, and LTS...
Core–shell particles are very well known for their unique features. Their distinctive inner core and outer shell structure allowed promising...
A total of 378 novel drugs and 27 biosimilars approved by the U.S. Food and Drug Administration (FDA) between 2010...
A drug dissolution profile is one of the most critical dosage form characteristics with immediate and controlled drug release. Comparing...
The Center for Drug Evaluation and Research (CDER) has launched the voluntary Novel Excipient Review Pilot Program (Pilot Program), which...
Oral cannabidiol (CBD) is approved by the Food and Drug Administration (FDA) to treat patients with Dravet and Lennox-Gastaut syndromes,...
Cannabidiol (CBD) is an alkaloid that can be found in the Cannabis species, currently used in United States of America...
Copyright: PharmaExcipients AG